img

Global Gene Deletion Vaccine Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 411 | Industry : Medical Care

Publisher : GRD Survey | Format : PDF

Global Gene Deletion Vaccine Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Gene Deletion Vaccine market is estimated at million US$ in 2021 and is expected to million US$ by the end of 2028, growing at a CAGR of % in the forecast period from 2022 to 2028.

This report studies the Gene Deletion Vaccine market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Gene Deletion Vaccine in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Single Gene Deletion Vaccine
Double Gene Deletion Vaccine

Market Snapshot, By Application
Animal Health Center
Veterinary Clinic

Main Market Players Analyzed in this report, including
Zoetis Inc
Virbac SA
Merck Animal Health
Indian Immunologicals Ltd
Heska Corporation
Ceva
Boehringer Ingelheim GmbH
Biogenesis-Bago
Bayer

The study objectives of this report are
To study and analyze the global Gene Deletion Vaccine market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Gene Deletion Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Gene Deletion Vaccine manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gene Deletion Vaccine market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Gene Deletion Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Gene Deletion Vaccine are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Global Gene Deletion Vaccine Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028.pdf

List of Figure

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Gene Deletion Vaccine Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Gene Deletion Vaccine Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Gene Deletion Vaccine

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Animal Health Center
3.2.2 Major Buyers in Veterinary Clinic

4 Market Segment: by Type
4.1 Gene Deletion Vaccine Type Introduction
4.1.1 Single Gene Deletion Vaccine
4.1.2 Double Gene Deletion Vaccine
4.2 Global Gene Deletion Vaccine Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 Gene Deletion Vaccine Type Introduction
5.1.1 Animal Health Center
5.1.2 Veterinary Clinic
5.2 Global Gene Deletion Vaccine Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Gene Deletion Vaccine Market by Region
6.2 North America Gene Deletion Vaccine Market 2016-2021
6.3 Europe Gene Deletion Vaccine Market 2016-2021
6.4 Asia Pacific Gene Deletion Vaccine Market 2016-2021
6.5 South America Gene Deletion Vaccine Market 2016-2021
6.6 Middle East and Africa Gene Deletion Vaccine Market 2016-2021

7 North America
7.1 North America Gene Deletion Vaccine Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Gene Deletion Vaccine Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Gene Deletion Vaccine Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Gene Deletion Vaccine Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Gene Deletion Vaccine Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Zoetis Inc
12.1.1 Zoetis Inc Company Information
12.1.2 Zoetis Inc Gene Deletion Vaccine Product Portfolio, Specification and Application
12.1.3 Zoetis Inc Gene Deletion Vaccine Revenue and Gross Margin (2019-2021)
12.1.4 Zoetis Inc Key Development
12.2 Virbac SA
12.2.1 Virbac SA Company Information
12.2.2 Virbac SA Gene Deletion Vaccine Product Portfolio, Specification and Application
12.2.3 Virbac SA Gene Deletion Vaccine Revenue and Gross Margin (2019-2021)
12.2.4 Virbac SA Key Development
12.3 Merck Animal Health
12.3.1 Merck Animal Health Company Information
12.3.2 Merck Animal Health Gene Deletion Vaccine Product Portfolio, Specification and Application
12.3.3 Merck Animal Health Gene Deletion Vaccine Revenue and Gross Margin (2019-2021)
12.3.4 Merck Animal Health Key Development
12.4 Indian Immunologicals Ltd
12.4.1 Indian Immunologicals Ltd Company Information
12.4.2 Indian Immunologicals Ltd Gene Deletion Vaccine Product Portfolio, Specification and Application
12.4.3 Indian Immunologicals Ltd Gene Deletion Vaccine Revenue and Gross Margin (2019-2021)
12.4.4 Indian Immunologicals Ltd Key Development
12.5 Heska Corporation
12.5.1 Heska Corporation Company Information
12.5.2 Heska Corporation Gene Deletion Vaccine Product Portfolio, Specification and Application
12.5.3 Heska Corporation Gene Deletion Vaccine Revenue and Gross Margin (2019-2021)
12.5.4 Heska Corporation Key Development
12.6 Ceva
12.6.1 Ceva Company Information
12.6.2 Ceva Gene Deletion Vaccine Product Portfolio, Specification and Application
12.6.3 Ceva Gene Deletion Vaccine Revenue and Gross Margin (2019-2021)
12.6.4 Ceva Key Development
12.7 Boehringer Ingelheim GmbH
12.7.1 Boehringer Ingelheim GmbH Company Information
12.7.2 Boehringer Ingelheim GmbH Gene Deletion Vaccine Product Portfolio, Specification and Application
12.7.3 Boehringer Ingelheim GmbH Gene Deletion Vaccine Revenue and Gross Margin (2019-2021)
12.7.4 Ceva Key Development
12.9 Bayer
12.9.1 Bayer Company Information
12.9.2 Bayer Gene Deletion Vaccine Product Portfolio, Specification and Application
12.9.3 Bayer Gene Deletion Vaccine Revenue and Gross Margin (2019-2021)
12.9.4 Bayer Key Development
12.8.1 Biogenesis-Bago Company Information
12.8.2 Biogenesis-Bago Gene Deletion Vaccine Product Portfolio, Specification and Application
12.8.3 Biogenesis-Bago Gene Deletion Vaccine Revenue and Gross Margin (2019-2021)
12.8.4 Biogenesis-Bago Key Development

13 Global Gene Deletion Vaccine Market Forecast by Region by Type and by Application
13.1 Global Gene Deletion Vaccine Revenue Forecast 2022-2027
13.2 Global Gene Deletion Vaccine Forecast by Regions
13.3 Global Gene Deletion Vaccine Forecast by Type
13.4 Global Gene Deletion Vaccine Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer